Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

UROMITEXAN TABLETS 400 mg

Approval Number

SIN10703P

Drug Name

UROMITEXAN TABLETS 400 mg

Product Name

UROMITEXAN TABLETS 400 mg

Approval Date

January 25, 1999

Registrant

BAXTER HEALTHCARE (ASIA) PTE LTD

Licence Holder

BAXTER HEALTHCARE (ASIA) PTE LTD

Regulatory Information

Registrant

BAXTER HEALTHCARE (ASIA) PTE LTD

Licence Holder

BAXTER HEALTHCARE (ASIA) PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET, FILM COATED

Route of Administration

ORAL

Medical Information

ATC Code

V03AF01

ATC Item Name

mesna

Manufacturer Information

Pharmaceutical Manufacturer

BAXTER HEALTHCARE (ASIA) PTE LTD

Manufacturers

TEMMLER PHARMA GMBH

Active Ingredients

Ingredient Name

MESNA

Strength

400 mg

Drug MonographCoenzyme M

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

UROMITEXAN TABLETS 400 mg - HSA Approval | MedPath